Literature DB >> 21707466

IMP-type metallo-β-lactamases in Gram-negative bacilli: distribution, phylogeny, and association with integrons.

Wei-Hua Zhao1, Zhi-Qing Hu.   

Abstract

Twenty-nine IMP-type β-lactamases (IMPs) have been identified in at least 26 species of clinically important Gram-negative bacilli from more than 24 countries/regions. Most of bla(IMP) genes are harbored by class 1 integrons that are usually embedded in transposons and/or plasmids, footnoting their horizontal transfer and worldwide distribution. bla(IMP) genes usually co-exist with other resistance genes, such as aacA, catB, and bla(OXA), resulting in multi-drug resistance. Compared to other gene cassettes, 76.3% of the bla(IMP) gene cassettes are located adjacent to Pc promoter of the class 1 integrons, indicating that the bla(IMP) genes are readily expressed in most of bacterial hosts.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21707466     DOI: 10.3109/1040841X.2011.559944

Source DB:  PubMed          Journal:  Crit Rev Microbiol        ISSN: 1040-841X            Impact factor:   7.624


  33 in total

1.  AcGI1, a novel genomic island carrying antibiotic resistance integron In687 in multidrug resistant Achromobacter xylosoxidans in a teaching hospital in Thailand.

Authors:  Pisut Pongchaikul; Pitak Santanirand; Svetlana Antonyuk; Craig Winstanley; Alistair C Darby
Journal:  FEMS Microbiol Lett       Date:  2020-07-01       Impact factor: 2.742

2.  pIMP-PH114 carrying bla IMP-4 in a Klebsiella pneumoniae strain is closely related to other multidrug-resistant IncA/C2 plasmids.

Authors:  Pak-Leung Ho; Wai-U Lo; Jane Chan; Yuk-Yam Cheung; Kin-Hung Chow; Wing-Cheong Yam; Chi-Ho Lin; Tak-Lun Que
Journal:  Curr Microbiol       Date:  2014-02       Impact factor: 2.188

3.  Complete sequence of an IncN plasmid, pIMP-HZ1, carrying blaIMP-4 in a Klebsiella pneumoniae strain associated with medical travel to China.

Authors:  Wai-U Lo; Yuk-Yam Cheung; Eileen Lai; David Lung; Tak-Lun Que; Pak-Leung Ho
Journal:  Antimicrob Agents Chemother       Date:  2012-12-28       Impact factor: 5.191

Review 4.  Overcoming differences: The catalytic mechanism of metallo-β-lactamases.

Authors:  María-Rocío Meini; Leticia I Llarrull; Alejandro J Vila
Journal:  FEBS Lett       Date:  2015-08-20       Impact factor: 4.124

5.  Two novel class I integron arrays containing IMP-18 metallo-β-lactamase gene in Pseudomonas aeruginosa clinical isolates from Puerto Rico.

Authors:  T Martínez; G J Vazquez; E E Aquino; R V Goering; I E Robledo
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

Review 6.  B1-Metallo-β-Lactamases: Where Do We Stand?

Authors:  Maria F Mojica; Robert A Bonomo; Walter Fast
Journal:  Curr Drug Targets       Date:  2016       Impact factor: 3.465

Review 7.  Carbapenem resistance: overview of the problem and future perspectives.

Authors:  Georgios Meletis
Journal:  Ther Adv Infect Dis       Date:  2016-02

8.  Carbapenem Use Is Driving the Evolution of Imipenemase 1 Variants.

Authors:  Zishuo Cheng; Christopher R Bethel; Pei W Thomas; Ben A Shurina; John-Paul Alao; Caitlyn A Thomas; Kundi Yang; Steven H Marshall; Huan Zhang; Aidan M Sturgill; Andrea N Kravats; Richard C Page; Walter Fast; Robert A Bonomo; Michael W Crowder
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

9.  Elucidating the Role of Residue 67 in IMP-Type Metallo-β-Lactamase Evolution.

Authors:  Alecander E LaCuran; Kevin M Pegg; Eleanor M Liu; Christopher R Bethel; Ni Ai; William J Welsh; Robert A Bonomo; Peter Oelschlaeger
Journal:  Antimicrob Agents Chemother       Date:  2015-09-14       Impact factor: 5.191

10.  Multiyear, Multinational Survey of the Incidence and Global Distribution of Metallo-β-Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa.

Authors:  Krystyna M Kazmierczak; Sharon Rabine; Meredith Hackel; Robert E McLaughlin; Douglas J Biedenbach; Samuel K Bouchillon; Daniel F Sahm; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2015-12-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.